Ribocure Pharmaceuticals
M├╢lndal
About Ribocure Pharmaceuticals
Ribocure Pharmaceuticals AB is a biotechnology company that focuses on the development of RNA-based therapeutics. The company's primary area of expertise lies in oligonucleotide therapeutics, a type of RNA-based treatment. Ribocure's team is dedicated to drug discovery in this field. The company also has a clinical trial unit, indicating its active involvement in research and development. Ribocure's business operations also include global business development, led by a Vice President and Head of Global Business Development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.0M
- Last round: Undisclosed (Jul 2025)
- Website: ribocure.com
- Phone: 46 559366-4377
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ribocure-pharmaceuticals-84591 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.